Style | Citing Format |
---|---|
MLA | Ramezani M, et al.. "A Crosstalk Between Epigenetic Modulations and Non-Alcoholic Fatty Liver Disease Progression." Pathology Research and Practice, vol. 251, no. , 2023, pp. -. |
APA | Ramezani M, Zobeiry M, Abdolahi S, Hatami B, Zali MR, Baghaei K (2023). A Crosstalk Between Epigenetic Modulations and Non-Alcoholic Fatty Liver Disease Progression. Pathology Research and Practice, 251(), -. |
Chicago | Ramezani M, Zobeiry M, Abdolahi S, Hatami B, Zali MR, Baghaei K. "A Crosstalk Between Epigenetic Modulations and Non-Alcoholic Fatty Liver Disease Progression." Pathology Research and Practice 251, no. (2023): -. |
Harvard | Ramezani M et al. (2023) 'A Crosstalk Between Epigenetic Modulations and Non-Alcoholic Fatty Liver Disease Progression', Pathology Research and Practice, 251(), pp. -. |
Vancouver | Ramezani M, Zobeiry M, Abdolahi S, Hatami B, Zali MR, Baghaei K. A Crosstalk Between Epigenetic Modulations and Non-Alcoholic Fatty Liver Disease Progression. Pathology Research and Practice. 2023;251():-. |
BibTex | @article{ author = {Ramezani M and Zobeiry M and Abdolahi S and Hatami B and Zali MR and Baghaei K}, title = {A Crosstalk Between Epigenetic Modulations and Non-Alcoholic Fatty Liver Disease Progression}, journal = {Pathology Research and Practice}, volume = {251}, number = {}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Ramezani M AU - Zobeiry M AU - Abdolahi S AU - Hatami B AU - Zali MR AU - Baghaei K TI - A Crosstalk Between Epigenetic Modulations and Non-Alcoholic Fatty Liver Disease Progression JO - Pathology Research and Practice VL - 251 IS - SP - EP - PY - 2023 ER - |